可解释的动态定向图卷积网络用于多关系预测误解突变和药物反应
IEEE journal of biomedical and health informatics
|October 18, 2024
概括
由于瘤异质性,预测癌症药物反应是复杂的. 一个新的可解释动态定向图卷积网络 (IDDGCN) 模型准确地预测了药物反应,并解释了它的推理.
科学领域:
- 在瘤学瘤学.
- 计算生物学 计算生物学
- 生物信息学是一种生物信息学.
背景情况:
- 瘤异质性使药物反应的预测变得复杂,因为单个基因内的错误突变可以产生不同的结果.
- 现有的用于药物反应预测的深度学习模型往往缺乏可解释性,作为药物反应预测模型而起作用.
- 黑盒子就是黑盒子.
- 并没有捕捉到复杂的突变-药物关系.
研究的目的:
- 开发一种先进的分析框架,用于预测瘤异质性背景下的药物反应.
- 提高深度学习模型在瘤学药物反应预测中的可解释性.
主要方法:
- 提出了一个可解释的动态定向图形卷积网络 (IDDGCN) 框架.
- 利用定向图来区分灵敏度和耐药性,动态更新节点重量,并探索基因内突变关联.
- 整合了加权机制和地面真相构建,以提高模型的解释性和透明度.
主要成果:
- 与现有最先进的模型相比,IDDGCN框架显示出优越的预测性能.
- 定性和定量评估都证实了该模型的强烈可解释性,为其预测提供了透明的解释.
- 该模型有效地捕捉了误解突变和药物反应之间的复杂关系.
结论:
- IDDGCN提供了一种强大且可解释的方法来预测癌症药物反应,解决当前方法的局限性.
- 这一框架为精确瘤学提供了一个新的视角,有助于向药物开发和个性化治疗策略.
更多相关视频
00:06In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
13.6K
07:08Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues
Published on: July 14, 2015
7.2K
相关概念视频
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
Dose-Response Relationship: Overview
3.0K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.0K
